China Drug Administration - Beijing Acctrue Technology Co., Ltd. was Founded in 2004, is a China’s leading company in building the ecological traceability system of the entire industry chain, takes one barcode for one item as the code, and relying on it
As part of the evaluation process, drug samples from three separate batches are rigorously tested. This critical examination is carried out by the National Institute for Food and Drug Control Center (NIFDC). The CDE takes a systematic approach to organizing technical reviewers who form panels respon...
Article 5: The drug administration department of the State Council (hereinafter interpreted as "SDA") shall be in charge of national drug administration affairs. Other relevant departments of the State Council shall be responsible for the drug administration affairs within t...
其中说明,因报盘软件中所涉及"CFDA"英文简称变更为"NMPA",自2018年9月1日起,请药品注册申报单位及时下载药品注册新版报盘程序进行填报。 众所周知,自2008年起,CFDA就一直作为China Food and Drug Administration的简称使用至今。 然而,此番由CFDA变更为NMPA ( National Medical Products Administration ) ,实际上,是...
Tian's efforts recently paid off. On March 15, China's National Medical Products Administration (NMPA) announced the approval of a new medicine developed by his company, a kind of kinase inhibitor that is helpful for combating melanoma.
On August 26, 2019, China's Standing Committee of National People's Congress (“NPC) adopted a significant revision of the Drug Administration Law (“DAL”). The newly adopted DAL (“Revised DAL”) will go into effect...
DRUG ADMINISTRATION LAW OF THE PEOPLE’S REPUBLIC OF CHINA （Adopted at the 7th Meeting of the Standing Committee of the Sixth National People’s Congress on September 20,1984, revised at the 20th Meeting of the Standing Committee of the Ninth National People’s Congress on February 28, 2001...
The China National Medical Products Administration or NMPA is the national regulatory body and competent authority for medical devices and in-vitro diagnostics (IVDs) in China. In 2018, the name was changed from the State Food and Drug Administration or SFDA to the NMPA. The NMPA is based in...
China’sNational Medical Products Administration(NMPA) is the overarching government agency that approves drugs. Under the NMPA, the Center for Drug Evaluation (CDE) does the initial review. Drugs are classified in China as – 1. Small molecule drugs, 2. Traditional Chinese Medicine, or 3.Therap...
KEYTRUDA Approved By China National Drug Administration (CNDA) in Five Months, Accelerating Availability of Anti-PD-1 Option to Advanced Melanoma Patients in China Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA®, Merck’s...